Polatuzumab vedotin and CD79B: A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphoma.

ABSTRACT:

SUBMITTER: Munz N 

PROVIDER: S-EPMC12710110 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature